Singapore - 10 May 2011
The medical device company BioMers Pte Ltd has named David Edwards its new Chief Executive Officer. Mr. Edwards will be leveraging his extensive experience in building brands to drive BioMers" commercial expansion and launch of flagship product, SimpliClear™, worldwide. SimpliClear™ is the world's only completely translucent orthodontic system. Mr. Edwards is based in BioMers" Singapore headquarters being responsible for the company's worldwide business, reporting to the Board of Directors.
Mr. Edwards brings broad management and global brand development experience in the consumer and med-tech space to the company, and has an impressive track record in growing businesses in the US, Europe and Asia.
Most recently, Mr Edwards served as the President of Asia-Pacific at Bausch & Lomb, responsible for the Asian eye health portfolio. In this role, he oversaw sales & marketing, medical and regulatory affairs, business operations and business development efforts; and was responsible for annual sales of over 500 million USD. Under his leadership, Bausch & Lomb's business in Asia was successfully turned around and several products were introduced to the market. Mr Edwards has also spent more than ten years with Johnson & Johnson in several top management positions. This includes roles as business unit head at Johnson & Johnson‟s diabetes business (encompassing Western Europe, Eastern Europe, Middle East and Africa), the vision care business (Asia Pacific including China and India) and the consumer nutritionals business (Europe). He achieved strong growth in his relevant areas, with the successful launch of numerous products and product innovations. Further positions include local, regional and global roles at Nestlé in the US, in Europe, and at the global headquarters in Vevey, Switzerland.
David Edwards comments on his new position: "I am looking forward to my new role at BioMers. SimpliClear™ is a proven product, which has been long awaited by orthodontists and patients. It represents a breakthrough innovation in the growing market for aesthetic orthodontic appliances, and delivers superior clinical outcomes."
Dr. Mervyn Fathianathan added: "With David Edwards, we have brought a top executive into BioMers who will contribute to make the company a global leader in orthodontics. His commitment highlights the value of our product and company. This marks the start of rapid expansion of the company's business on a global scale."
David Edwards succeeds Dr. Mervyn Fathanathian as the CEO. Dr. Fathianathan is one of the founders and a director of BioMers. He will continue as the CTO of BioMers, and shall be responsible for customer and product development.
BioMers is a medical device company that has developed novel polymer composite products based on nanotechnology for numerous biomedical applications. The company's flagship product is the SimpliClear™ braces system, which is the world's first and only aesthetic solution for all types of orthodontic treatments. This translucent, almost invisible braces system is customized to each patient, providing faster and better results. Established in 2005, BioMers is a spin-off company from the National University of Singapore, where the technology was invented. It has received venture capital investment from Nanostart AG, a venture capital fund publicly listed on the German stock exchange focussed on nanotechnology investments. For more information, please visit www.biomersbraces.com.
Ayesha Pinto
Marketing Manager - BioMers Pte Ltd
Email: ayesha@biomersbraces.com